EPIGRAL
Meghmani Finechem
Each stock's 10,000-path forecast, rendered as light.
Meghmani Finechem (EPIGRAL) Stock Analysis & Case Study
Is EPIGRAL a good buy? The data-driven verdict.
Meghmani Finechem (EPIGRAL) trades at ₹1,133,on the numbers it mixed signals, a Downstox Snapshot Score of 54/100.
On the numbers, Meghmani Finechem (EPIGRAL) mixed signals, a Downstox Snapshot Score of 54/100, weighing inexpensive at 14.8× earnings, ROE of 16.0%, a 32% model probability of trading higher in a year. Below: the full bull case, bear case, sector-relative valuation, and a probability-weighted price target for 2027–2031.
Last updated . Data snapshot for research, not investment advice.
EPIGRAL fundamentals at a glance, PE, PB, ROE, ROCE, market cap, dividend yield
Is EPIGRAL overvalued? EPIGRAL P/E vs its sector
EPIGRAL's P/E of 14.8× sits above the sector peer median of 14.8×, so on earnings it screens in line with peers, while its 0.44% dividend yield is below the peer median of 1.65%.
EPIGRAL share price target 2027, 2028, 2029, 2030, 2031, a probability view
Unlike a single guessed number, this is a probability-weighted range from a 10,000-path Monte-Carlo simulation on 2.0y of EPIGRAL history (-9%/yr drift, 48%/yr volatility).
| Year | Low (P10) | Median target (P50) | High (P90) | Upside vs today |
|---|---|---|---|---|
| EPIGRAL 2027 | ₹502 | ₹911 | ₹1,668 | -19% |
| EPIGRAL 2028 | ₹317 | ₹735 | ₹1,754 | -35% |
| EPIGRAL 2029 | ₹209 | ₹606 | ₹1,724 | -46% |
| EPIGRAL 2030 | ₹150 | ₹486 | ₹1,690 | -57% |
| EPIGRAL 2031 | ₹104 | ₹405 | ₹1,617 | -64% |
Median (P50) is the central estimate; the P10–P90 band is the 80% confidence range. Probabilities, not promises.
What is the probability EPIGRAL goes up, or doubles?
The bull case for EPIGRAL
- Trades at just 14.8× earnings, below the ~22× long-run Nifty average, so the valuation leaves room rather than pricing in perfection.
- A healthy 16.0% return on equity.
- Upside scenario: the model's optimistic (P90) 3-year path reaches ₹1,724.
The bear case & risks
- The probability model is cautious 12 months out, only a 32% chance of finishing above today's price.
- High historical volatility (48%/yr) means a wide, bumpy range of outcomes, size positions accordingly.
- Downside scenario: the model's pessimistic (P10) 3-year path falls to ₹209.
EPIGRAL volatility & expected range, how bumpy is the ride?
Over the last 2.0 years EPIGRAL compounded at -9%/year with annualized volatility of 48%. That volatility implies a 1-year 80% range of ₹502–₹1,668, the honest backbone behind any single price target.
EPIGRAL price forecast, the full 60-month probability fan
EPIGRAL price probability fan
Each band shows where 10,000 simulated paths land. The wider the fan, the more uncertainty.
Probability of key outcomes
What are the odds EPIGRAL hits common targets within the simulated horizon?
Full multi-horizon detail on the EPIGRAL price target & forecast page.
EPIGRAL Piotroski F-Score: 4/9, how financially strong is it?
The Piotroski F-Score grades financial strength on nine profitability, leverage and efficiency checks. EPIGRAL scores 4/9,mixed financial health.
EPIGRAL MTF margin & leverage, Upstox, Zerodha, Groww, Dhan
Margin Trading Facility lets you buy EPIGRAL with part of the capital. Lower margin % = higher leverage. Rates compared across brokers (no competitor publishes this):
| Broker | Margin required | Approx. leverage |
|---|---|---|
| UpstoxCHEAPEST | 35.6% | 2.8× |
| ZerodhaCHEAPEST | 35.6% | 2.8× |
| DhanCHEAPEST | 35.6% | 2.8× |
Compare every broker on the EPIGRAL MTF page.
EPIGRAL vs peers,sector comparison
About Meghmani Finechem: sector, index & market-cap context
Meghmani Finechem (EPIGRAL) is a small-cap NSE-listed company, and a constituent of the Nifty 500 index group, with a market capitalisation of ₹4,887 Cr. See more Nifty 500 stocks.
How the EPIGRAL Snapshot Score & forecast are built
The Downstox Snapshot Score is a transparent, rules-based read of Meghmani Finechem's public fundamentals plus a statistical forecast, not an analyst opinion. It rewards low-to-fair valuation, high ROE/ROCE, a strong Piotroski F-Score, a dividend, low volatility and a favourable probability of upside; it penalises rich valuations, weak capital efficiency, a low F-Score and high volatility. The price target is a 10,000-path Monte-Carlo simulation on real historical volatility, a distribution, not a single guess. The bull and bear cases are generated from the same data, so you always see both sides.
This is information, not investment advice. Do your own due diligence and consult a SEBI-registered adviser before investing.
EPIGRAL analysis, FAQs
Is Meghmani Finechem (EPIGRAL) a good buy?
On the numbers, Meghmani Finechem (EPIGRAL) mixed signals, a Downstox Snapshot Score of 54/100, weighing inexpensive at 14.8× earnings, ROE of 16.0%, a 32% model probability of trading higher in a year. This is a data snapshot for research, not investment advice.
Is EPIGRAL overvalued or undervalued?
EPIGRAL trades at 14.8× earnings versus a peer median of 14.8×, so it screens richer than its sector peers.
What is the EPIGRAL share price target for 2031?
EPIGRAL's probability-weighted 2031 median target is ₹405, with an 80% range of ₹104–₹1,617 (10,000-path Monte-Carlo).
What is the probability EPIGRAL doubles in 5 years?
The modelled probability of EPIGRAL reaching ₹2,255 (2×) within 5 years is 5%.
What is the bull case for EPIGRAL?
Trades at just 14.8× earnings, below the ~22× long-run Nifty average, so the valuation leaves room rather than pricing in perfection. A healthy 16.0% return on equity.
What are the risks in EPIGRAL?
The probability model is cautious 12 months out, only a 32% chance of finishing above today's price. High historical volatility (48%/yr) means a wide, bumpy range of outcomes, size positions accordingly.